Accelerate drug discovery with NVIDIA BioNeMo™ for biopharma, a collection of frameworks, applications, generative AI solutions, and pretrained models.
BioNeMo Framework is an open-source machine learning framework for building and training deep learning models for biopharma.
By accelerating the most expensive and prolonged aspects of AI model development, AI model builders doing biomolecular research with DNA, RNA, and protein data can access tools to scale their research to new heights.
The platform includes curated training recipes, data loaders, and pre-trained, optimized example AI model architectures that are domain-specific and accelerated for the best performance, making AI model building faster and simpler.NVIDIA BioNeMo Blueprints are pretrained reference workflows designed for generative AI applications in drug discovery, offering biopharma teams a foundation to accelerate research and innovation.
For organizations in biopharma looking to integrate AI, these blueprints include reference code, tools, and comprehensive documentation to customize and deploy workflows tailored to proprietary data and unique therapeutic pipelines.
These resultant data flywheels enhance model performance over time, driving deeper insights and accelerating discovery. BioNeMo Blueprints enable biopharma to streamline innovation and unlock the potential of AI in drug development.
NVIDIA BioNeMo NIM™ includes a set of optimized, easy-to-use AI microservices built to enable gigascale inference and enable new capabilities in drug design.
Built for computational drug discovery platform developers and data scientists, NIM microservices are constructed as containers with everything needed for the most efficient, portable deployment available for easy API integration into enterprise-grade AI applications.
NIM microservices increase the efficiency and innovation of drug discovery workflows while decreasing the total cost of ownership and time to market for your AI-driven discoveries.
Find a collection of documents, guides, manuals, how-tos, and more in the NVIDIA BioNeMo Documentation Hub.
Get notified of new releases, bug fixes, critical security updates, and more for biopharma.
NVIDIA BioNeMo is a generative AI platform for chemistry and biology. It provides drug discovery researchers and developers a fast and easy way to build and integrate state-of-the-art generative AI applications across the entire drug discovery pipeline, from target identification to lead optimization. The platform offers workflows for 3D protein structure prediction, de novo design, virtual screening, docking, and property prediction.
NVIDIA BioNeMo Framework is a collection of programming tools and libraries that streamline the building and adapting of biomolecular AI models, accelerating the most time-consuming and costly stages of computational drug discovery.
NVIDIA NIM microservices are a set of optimized, easy-to-use, portable microservices designed for biomolecular scientists in drug discovery needing secure, reliable AI model inferencing.
NVIDIA BioNeMo Framework: Users can access the BioNeMo Framework in two ways. NVIDIA’s offering for enterprise-grade use of BioNeMo with an NVIDIA AI Enterprise license offers the BioNeMo container via the NVIDIA GPU Cloud, which provides enterprise developers and researchers with a secure, scalable toolchain to build biomolecular workflows. The open-source version of BioNeMo that researchers and data scientists use is available for installation from GitHub, including all of its components.
See the latest list of system requirements for BioNeMo Framework on the NGC Catalog Container page.
See the latest system requirements for NIM microservices at NVIDIA API Documentation.
Please contact us with your question.